Novavax receives a sales rating. It has a Covid vaccine problem, analysts say.

Text size A healthcare professional is preparing a dose of Nuvaxovid vaccine. Jeroen Jumelet / ANP / AFP via Getty Images Novavax the stock fell on Friday after receiving a sales equivalent rating – the first since December 2020 and the only one from Wall Street. Bank of America Securities analyst Alec Stranahan began coverage … Read more

The technician, who called the 2020 market bottom, says a ‘shocking rally’ is on the way

It has been a terrible week in a terrible year for the stock market. Walmart WMT, -2.74%, Target TGT, -5.06%, and Tencent 700, +3.53% each reported disappointing results to add fuel to concerns about rate hikes and quantitative easing. But apart from Melvin Capital, there have been no signs of capitulation. Over the past six … Read more

Tesla Shanghai delays second shift. Here is when things get normal again.

Text size An aerial photo of Tesla’s Shanghai Gigafactory Xiaolu Chu / Getty Images Tesla has delayed the return of production at its Shanghai plant to levels ahead of the city’s strict Covid-19 lockdowns by at least a week. Pandemic restrictions remain a problem for the entire automotive industry, but the end seems to be … Read more

The stock market today: Dow Futures faltering, oil prices falling after weak Chinese data

Text size Shares have been sold in recent weeks due to investors’ concerns about inflation and growth. Ed Jones / AFP via Getty Images Equities faltered as weak data from China revealed how Covid-19 lockdowns have weighed on the world’s second-largest economy, raising investors’ concerns about global growth. Futures for Dow Jones Industrial Average retreated … Read more

BioNTech Earnings Top Forecasts on Strong Sales of Covid-19 Vaccine

Text size The BioNTech logo on the facade of its manufacturing site in Marburg, central Germany. (Photo by THOMAS LOHNES / AFP via Getty Images) BioNTech , the German biotech company, reported first-quarter earnings and sales that topped Wall Street expectations. The company, which partnered with Pfizer to develop the first Covid-19 vaccine approved for … Read more

Stock Market Today: Dow Futures Slide, Tech Sells Off, Bond Yields Surge

Text size Stocks have had a tough 2022, with the S&P 500 firmly in correction territory. Dreamstime Stocks slipped on Monday with last week’s selloff resuming, as investors fretted about the economic impact of Federal Reserve policy and the ramifications of continued Covid-19 lockdowns in China. Futures for the Dow Jones Industrial Average retreated 400 … Read more

Oil Prices Slip as Saudi Arabia Cuts Prices and China Lockdowns Intensify

Text size Oil prices slip Monday but are still elevated. Pichit Boonhuad / Dreamstime.com Oil prices declined Monday after Saudi Arabia, the biggest exporter, reduced prices for Asia and the northwest of Europe. Tighter lockdowns in China to prevent the spread of new Covid-19 outbreaks, as well as signs of a broader global economic slowdown, … Read more

Royal Caribbean’s New CEO Talks Profit, Debt, and Consumers’ Post-Covid Mindset

Royal Caribbean CEO Jason Liberty credits the cruise operator’s relationships with its bankers as a key to getting ‘affordable capital’ to keep it afloat during the pandemic. Here, Royal’s Anthem of the Seas cruise ship in Scotland last year. Jeff J Mitchell / Getty Images Text size There are signs that the cruise industry, which … Read more

Carvana, Robinhood and Teladoc Stock Give Way to Old-School Rivals. Here’s When It Might Be Safe to Buy.

Text size Carvana’s stock has fallen nearly 80% in the past 12 months. Mark Ralston / AFP / Getty Images It’s new school versus old school, and the new school does not stand a chance. No, we’re not talking about the NBA playoffs, where the upstart Memphis Grizzlies have the resurgent Golden State Warriors locked … Read more

Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales

Text size Illumina turned in stronger financial results than expected. Dreamstime The gene-sequencing supplier Illumina delivered on its March quarter financial forecasts, as global demand for genetically-informed cancer treatment made up for Covid lockdowns at China’s labs, but Wall Street analysts cut their forecasts for the stock price regardless. In calls Thursday, the company reaffirmed … Read more

Advertise